Catalyst Wire Dossier Catalyst Wire Dossier

CLINDAMYCIN PALMITATE HYDROCHLORIDE

Clindamycin palmitate hydrochloride · Chartwell RX, LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CLINDAMYCIN PALMITATE HYDROCHLORIDE, covering 2017-05-05 to 2024-04-15. Get the full timeline:

Most recent: FDA Approved: CLINDAMYCIN PALMITATE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)

See pricing